Osmohale (Mannitol)

Mannitol, the active ingredient in Osmohale, is an osmotic diuretic presented as a sterile powder for intravenous use. It is employed in renal diuresis and osmotherapy, particularly in acute kidney injury and to reduce intracranial pressure in critical care settings.

GNH USA supplies Osmohale as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Osmohale is an osmotic diuretic that acts on renal water handling and intracranial fluid dynamics. It is indicated for: - Acute kidney injury: facilitates diuresis to manage fluid overload. - Cerebral edema: reduces intracranial pressure by creating an osmotic gradient. - Glaucoma surgery: assists in intra‑ocular pressure control during operative procedures.

Adverse reactions to mannitol may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: occasional upset stomach. - Electrolyte imbalance: changes in sodium or potassium levels. - Transient hypotension: brief drop in blood pressure. - Pulmonary edema: fluid accumulation in the lungs.

Serious or Rare Side Effects: - Acute renal failure: sudden loss of kidney function. - Severe hyponatremia: dangerously low sodium concentration. - Anaphylaxis: life‑threatening allergic reaction. - Hyperosmolar coma: extreme increase in plasma osmolarity. - Intracerebral hemorrhage: bleeding within the brain tissue.

When using Osmohale, clinicians should consider several safety measures: - Renal function monitoring: assess baseline and ongoing kidney performance. - Fluid balance assessment: track input‑output records. - Electrolyte surveillance: check serum sodium and potassium regularly. - Cardiovascular status: observe for hypotension or cardiac stress. - Contraindications review: avoid in patients with established severe renal impairment. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Mannitol may interact with several concomitant medications.

Major Interactions (Avoid): - Loop diuretics: combined use can intensify volume depletion. - Nephrotoxic antibiotics: may increase risk of renal injury. - Insulin: rapid shifts in plasma osmolarity can alter glucose control.

Moderate Interactions (Monitor Closely): - Antihypertensives: may potentiate hypotensive effects. - Cardiac glycosides: fluid shifts can affect drug plasma levels. - Anticoagulants: altered renal clearance may modify anticoagulant activity.